Earnings call Kuros Biosciences posted FY25 revenue of $146.1M (+72% YoY), adjusted EBITDA of $19.6M (13.4% margin), and first-ever net profit of $2.6M, exceeding guidance. Management guides for at ...
VPNs encrypt your traffic, but they aren't blind to your activity. Here's the metadata your provider can see—and how to spot services that misuse it.
Mullvad’s New WireGuard Implementation Put to the Test in Latest Audit ...
Zero-days in .NET and SQL Server, and a handful of critical RCE bugs, form the nucleus of Microsoft's March Patch Tuesday update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results